- TCTCN replaces BMTCN effective January 1, 2026, with testing delivered through PSI.
- The exam has 165 questions (125 scored, 40 unscored) in a 3-hour session with no scheduled breaks.
- Passing requires a scaled score of 55 on a 25-75 scale.
- Four domains each carry 22% of the exam: Foundations, Process/Administration, Post-HSCT Management, and Post-Cellular Therapy Management.
What Changed for TCTCN in 2026
The credential formerly known as BMTCN is now the Transplantation and Cellular Therapy Certified Nurse (TCTCN) designation, a renaming that took effect January 1, 2026. The Oncology Nursing Certification Corporation (ONCC) still administers it, and it remains NCCA-accredited, but the content and title now reflect the broader scope of cellular therapy nursing beyond traditional hematopoietic stem cell transplant (HSCT) care. Testing moved to PSI test centers, and the 2026 content outline is built from a 2024 role delineation study, meaning the blueprint reflects current practice patterns rather than legacy transplant-only protocols.
If you are still researching the basics of this credential before diving into review material, start with What Is TCTCN? or TCTCN Meaning for background, then come back here for the condensed facts. This page is meant to function as a single-screen reference you can scan the night before your test - not a substitute for the deeper preparation covered in the TCTCN Study Guide 2026.
Exam Format at a Glance
Every question on the TCTCN exam is four-option multiple choice - there are no multi-select, drag-and-drop, or calculation-entry formats. That consistency matters for pacing: you always have exactly four choices to evaluate, so elimination strategies work the same way on every item.
- Total questions: 165 (125 scored, 40 unscored pretest items you cannot distinguish from scored items)
- Time allowed: 3 hours for the full session
- Breaks: None scheduled - the tutorial and post-test survey are built into the 3-hour window
- Delivery: Computer-based testing through PSI
- Format: All items are four-option multiple choice
Because 40 of the 165 questions are unscored pretest items mixed invisibly among the scored ones, there is no way to identify or skip them. Treat every question with equal seriousness. For a deeper breakdown of how difficult candidates typically find this pacing and question style, see How Hard Is the TCTCN Exam? Complete Difficulty Guide 2026.
Key Takeaway
With no scheduled breaks across a 3-hour, 165-item session, build stamina during practice sessions on ../ so the pacing feels routine rather than draining on test day.
Registration, Fees, and Eligibility
TCTCN pricing is tiered by membership status:
| Requirement | Detail |
|---|---|
| Fee (ONS or APHON member) | $300 |
| Fee (nonmember) | $420 |
| RN license | Current, active, unencumbered |
| RN experience | At least 2 years |
| Practice hours | 2,000 hours of HSCT or cellular therapy nursing within the previous 4 years |
| Contact hours | 10 qualifying contact hours or an academic elective within the previous 3 years |
| Testing window | 90 days once approved |
| Certification validity | 4 years |
Note that the 2,000-hour practice requirement and the 10 contact hours are separate conditions - meeting one does not satisfy the other. If you want the full eligibility breakdown, including how to document hours and elective coursework, review TCTCN Requirements 2026: Eligibility, Prerequisites & How to Qualify. For the complete cost picture, including any renewal or retake considerations, see TCTCN Certification Cost 2026: Complete Pricing Breakdown.
The Six Domains: Quick Reference
The 2026 TCTCN outline organizes content into six domains, four of which are weighted equally and together make up the bulk of the exam:
| Domain | Weight |
|---|---|
| Foundations of HSCT and Cellular Therapy | 22% |
| HSCT and Cellular Therapy Process and Administration | 22% |
| Post-HSCT Management and Education | 22% |
| Post-Cellular Therapy Management and Education | 22% |
| Quality of Life | 8% |
| Professional Performance | 4% |
Notice that the four large domains split cleanly into two pairs: one pair covers foundational knowledge and the administration process, and the other pair covers post-treatment management - one for HSCT, one for cellular therapy specifically. This structure reflects the exam's dual focus on transplant and non-transplant cellular therapies as distinct but related clinical pathways. A full walkthrough of each domain's subtopics lives in TCTCN Exam Domains 2026: Complete Guide to All 6 Content Areas.
Foundations of HSCT and Cellular Therapy (22%)
Covers the science and rationale behind transplant and cellular therapy: disease indications, graft sources, conditioning regimen principles, and the biological basis for why these therapies work.
- Autologous vs. allogeneic transplant distinctions
- Graft sources: bone marrow, peripheral blood stem cells, cord blood
- HLA typing and donor selection basics
- Conditioning regimen categories and intent (myeloablative vs. reduced intensity)
HSCT and Cellular Therapy Process and Administration (22%)
Focuses on the mechanics of delivering therapy: cell collection, processing, infusion procedures, and the nursing role during administration.
- Apheresis and collection procedures
- Cryopreservation and product handling
- Infusion-related reactions and monitoring during administration
- Vascular access considerations for cell product delivery
Post-HSCT Management and Education (22%)
Addresses the clinical course after transplant, including complications specific to HSCT recipients and the education patients need for recovery.
- Graft-versus-host disease (GVHD) recognition and grading
- Engraftment syndrome and delayed engraftment
- Infection risk during immune reconstitution
- Long-term survivorship and late effects education
Post-Cellular Therapy Management and Education (22%)
Parallels the HSCT domain but centers on non-transplant cellular therapies such as CAR T-cell products, with distinct toxicity profiles.
- Cytokine release syndrome (CRS) grading and management
- Immune effector cell-associated neurotoxicity syndrome (ICANS)
- Monitoring timelines unique to cellular therapy products
- Patient and caregiver education specific to cellular therapy recovery
Must-Know Clinical Facts by Domain
Beyond memorizing domain names, candidates need fluency in how these topics show up as scenario-based questions. TCTCN items typically present a patient situation and ask you to select the best nursing action, prioritization, or interpretation - not a bare definition. A few high-yield patterns to internalize:
- Distinguish GVHD from CRS/ICANS symptoms - both can present with fever and organ involvement, but timing, triggers, and management diverge sharply between HSCT and cellular therapy pathways.
- Know grading systems, not just names - questions often hinge on recognizing a grade or stage from a described presentation rather than recalling a term in isolation.
- Sequence nursing actions - many items ask what the nurse should do first, testing prioritization under time-sensitive complications like anaphylaxis during infusion or acute neurotoxicity.
- Understand the Quality of Life domain's practical scope - at 8%, this smaller domain covers psychosocial support, survivorship concerns, and caregiver burden, often woven into scenario questions rather than tested standalone.
- Professional Performance at 4% - the smallest domain, but still scored; expect items on scope of practice, patient advocacy, and interdisciplinary collaboration.
Scoring and Passing Mechanics
ONCC reports TCTCN results on a 25-75 scaled score, and you need a 55 to pass. This is not a raw percentage - the scale accounts for question difficulty across the 125 scored items, so a 55 does not translate directly to "55% correct." Do not attempt to reverse-engineer your score from a personal item count during the test; focus instead on answering every question with full attention, since the 40 unscored pretest items are indistinguishable from the 125 that count.
For a complete explanation of how the scaled score is calculated and what it means for your preparation strategy, see TCTCN Passing Score 2026: Exactly What You Need to Pass. If you want context on how candidates generally perform, review TCTCN Pass Rate 2026: What the Data Shows.
Key Takeaway
A 55 on the 25-75 scale is your only target number. Don't waste mental energy during the exam trying to calculate your running score - there's no reliable way to do it in real time.
A Domain Priority Plan for Final Review Week
In the final week before your test date, allocate review time proportionally to domain weight rather than personal comfort level. Since four domains each carry 22%, they deserve roughly equal daily blocks, while Quality of Life (8%) and Professional Performance (4%) need lighter, targeted passes.
Foundations + Process/Administration
- Review graft sources, conditioning regimens, and collection/infusion procedures together since they build on each other
Post-HSCT Management
- Drill GVHD grading, infection timelines, and engraftment complications with scenario questions
Post-Cellular Therapy Management
- Focus on CRS and ICANS grading criteria and management sequencing, since these are frequently confused with GVHD symptoms
Quality of Life + Professional Performance
- Light review of survivorship, caregiver support, and scope-of-practice items - smaller weight but still scored
Full-length timed practice
- Simulate the 3-hour, 165-question session with no breaks to build stamina for the actual PSI test day
This structure mirrors the exam blueprint's own emphasis: nothing in the four major domains, and light touches on the two smaller ones. For a longer-horizon version of this plan spanning weeks instead of days, the TCTCN Study Guide 2026 lays out a fuller timeline.
Who This Cheat Sheet Is For
TCTCN certification is most relevant to RNs working in HSCT units, cellular therapy infusion centers, apheresis units, and outpatient survivorship clinics tied to transplant or CAR T-cell programs. Employers in these settings - academic transplant centers, comprehensive cancer centers, and specialty infusion clinics - often recognize the credential as a marker of specialized competency when hiring or promoting nurses into transplant and cellular therapy roles. If you're evaluating whether pursuing this credential fits your career path, Is the TCTCN Certification Worth It? Complete ROI Analysis 2026 and TCTCN Salary Guide 2026: Complete Earnings Analysis cover the broader value proposition, while TCTCN Jobs outlines typical roles that seek this certification.
This cheat sheet is intentionally condensed - it's a final-review companion, not a first-pass learning tool. Pair it with full-length practice exams on ../ to confirm you can apply these facts under real time pressure, and revisit the domain-specific guides linked throughout this page whenever a topic feels unfamiliar rather than just half-remembered.
FAQ
TCTCN is the renamed version of BMTCN, effective January 1, 2026. It is administered by ONCC and reflects an updated 2024 role delineation study with a broader scope covering both HSCT and cellular therapy content.
The exam has 165 four-option multiple-choice questions (125 scored, 40 unscored) delivered in a 3-hour session with no scheduled breaks.
You need a scaled score of 55 on ONCC's 25-75 scoring scale. This is not a raw percentage of correct answers.
You need a current, active, unencumbered RN license, at least 2 years of RN experience, 2,000 hours of HSCT or cellular therapy nursing practice within the previous 4 years, and 10 qualifying contact hours or an academic elective within the previous 3 years.
The fee is $300 for ONS or APHON members and $420 for nonmembers. Once approved, candidates receive a 90-day testing window through PSI.